Clinical Trial Update: Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of the triple combination niraparib, temozolomide, and atezolizumab in patients with advanced solid tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Niraparib (Niraparib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Advanced Malignant Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING